APA

Yust-Katz S., Liu D., Yuan Y., Liu V., Kang S., Groves M., Puduvalli V., Levin V., Conrad C., Colman H., Hsu S., Yung W. K. A. & Gilbert M. R. (20131203). Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. : Cancer.

Chicago

Yust-Katz Shlomit, Liu Diane, Yuan Ying, Liu Vivien, Kang Sanghee, Groves Morris, Puduvalli Vinay, Levin Victor, Conrad Charles, Colman Howard, Hsu Sigmonid, Yung W K Alfred and Gilbert Mark R. 20131203. Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. : Cancer.

Harvard

Yust-Katz S., Liu D., Yuan Y., Liu V., Kang S., Groves M., Puduvalli V., Levin V., Conrad C., Colman H., Hsu S., Yung W. K. A. and Gilbert M. R. (20131203). Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. : Cancer.

MLA

Yust-Katz Shlomit, Liu Diane, Yuan Ying, Liu Vivien, Kang Sanghee, Groves Morris, Puduvalli Vinay, Levin Victor, Conrad Charles, Colman Howard, Hsu Sigmonid, Yung W K Alfred and Gilbert Mark R. Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. : Cancer. 20131203.